Key statistics
On Friday, XOMA Royalty Corp (X0M1:STU) closed at 25.60, -5.19% below its 52-week high of 27.00, set on Jul 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.40 |
---|---|
High | 26.40 |
Low | 25.60 |
Bid | 25.20 |
Offer | 25.60 |
Previous close | 26.40 |
Average volume | 10.00 |
---|---|
Shares outstanding | 11.70m |
Free float | 11.64m |
P/E (TTM) | -- |
Market cap | 329.95m USD |
EPS (TTM) | -2.22 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Announcements
- XOMA Royalty to Present at Upcoming Investor Conferences in September
- XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
- XOMA Declares Quarterly Preferred Stock Dividends
- XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
- XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
- XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
- XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
- XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
- XOMA Corporation Announces Closing of Tender Offer
- XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
More ▼